Genes and neuroimaging: Advances in psychiatric research

Neurodegenerative Diseases

Volumn 5, Issue 5, 2008, Pages 277-285

  Gallinat, J ^a   Bauer, M ^a   Heinz, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Brain imaging, psychiatry; Catechol O methyltransferase; Endophenotype; Genetic variation; Intermediate phenotype; Serotonin transporter

Indexed keywords

CATECHOL METHYLTRANSFERASE; DYSBINDIN; NEU DIFFERENTIATION FACTOR; SEROTONIN TRANSPORTER;

ANXIETY DISORDER; BIPOLAR DISORDER; DEPRESSION; DNA POLYMORPHISM; ELECTROPHYSIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; MOLECULAR GENETICS; MORPHOMETRICS; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; WORKING MEMORY;

CATECHOL O-METHYLTRANSFERASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MENTAL DISORDERS; PHENOTYPE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 44649098286     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000135612     Document Type: Review

References (86)

1. Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-645.
2. Tsuang MT, Faraone SV: The future of psychiatric genetics. Curr Psychiatry Rep 2000;2:133-136.
3. Gallinat J, Heinz A: Combination of multimodal imaging and molecular genetic information to investigate complex psychiatric disorders. Pharmacopsychiatry 2006;39(suppl 1):S76-S79.
4. Rentzsch J, Jockers-Scherübl MC, Boutros NN, Gallinat J: Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol 2008;67:81-90.
5. Schubert F, Gallinat J, Seifert F, Rinneberg H: Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 tesla. Neuroimage 2004;21:1762-1771.
6. Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005;10:40-68.
7. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI: Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 1998;18:2697-2708.
8. Kneavel M, Gogos J, Karayiorgou K, Luine V: Interaction of COMT gene deletion and environment on cognition. Soc Neurosci Abst 2000;26:1-2.
9. Liljequist R, Haapalinna A, Ahlander M, Li YH, Mannisto PT: Catechol-O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res 1997;82:195-202.
10. Smolka MN, Schumann G, Wrase J, Grusser SM, Flor H, Mann K, Braus DF, Goldman D, Buchel C, Heinz A: Catechol-O-methyltransferase Val158Met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 2005;25:836-842.
11. 108/158 Met gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 2003;54:40-48.
12. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001;98:6917-6922.
13. Tsai SJ, Hong CJ, Hou SJ, Yen FC: Lack of association of catechol-O-methyltransferase gene Val108/158Met polymorphism with schizophrenia: a family-based association study in a Chinese population. Mol Psychiatry 2006;11:2-3.
14. Park TW, Yoon KS, Kim JH, Park WY, Hirvonen A, Kang D: Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur Neuropsychopharmacol 2002;12:299-303.
15. Ho BC, Wassink TH, O'Leary DS, Sheffield VC, Andreasen NC: Catechol-O-methyltransferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry 2005;10:229, 287-298.
16. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR: Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry 2003;60:889-896.
17. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman DA: Functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002;159:652-654.
18. Ohara K, Nagai M, Suzuki Y: Low activity allele of catechol-O- methyltransferase gene and Japanese unipolar depression. Neuroreport 1998;9:1305-1308.
19. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P: Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 1998;8:221-225.
20. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM: Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 1998;3:346-349.
21. Ohara K, Nagai M, Suzuki Y, Ochiai M: No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 1998;80:145-148.
22. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D: Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 2003;13:33-41.
23. Lang UE, Bajbouj M, Sander T, Gallinat J: Gender-dependent association of the functional catechol-O-methyltransferase Val-158Met genotype with sensation seeking personality trait. Neuropsychopharmacology 2007;32:1950-1955.
24. Palmatier MA, Kang AM, Kidd KK: Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 1999;46:557-567.
25. Keedwell PA, Andrew C, Williams SC, Brammer MJ, Phillips ML: The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 2005;58:843-853.
26. Miller LA, Taber KH, Gabbard GO, Hurley RA: Neural underpinnings of fear and its modulation: implications for anxiety disorders. J Neuropsychiatry Clin Neurosci 2005;17:1-6.
27. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998;95:9991-9996.
28. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
29. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, Linnoila M, Weinberger DR: A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000;47:643-649.
30. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
31. Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J: Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 2003;53:304-314.
32. Charney DS, Deutch A: A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996;10:419-446.
33. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M: Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 2001;115:358-364.
34. Lesch KP, Mössner R: Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998;44:179-192.
35. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, Virkkunen M, Linnoila M, Goldman D: Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998;55:936-940.
36. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR: Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297:400-403.
37. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR: 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005;8:828-834.
38. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, Mann K, Buchel C: Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005;8:20-21.
39. Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP: Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci USA 2005;102:12224-12229.
40. Drevets WC: Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829.
41. Malison RT, Price LH, Berman R, van Dyck CH, Pelton GH, Carpenter L, Sanacora G, Owens MJ, Nemeroff CB, Rajeevan N, Baldwin RM, Seibyl JP, Innis RB, Charney DS: Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 β-carbomethoxy-3 β-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 1998;44:1090-1098.
42. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, Staib LH, Charney DS: Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51:273-279.
43. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996;93:3908-3913.
44. McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR: Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 2000;36:85-94.
45. Malberg JE, Eisch AJ, Nestler EJ, Duman RS: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110.
46. Magarinos AM, Deslandes A, McEwen BS: Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999;371:113-122.
47. Gallinat J, Strohle A, Lang UE, Bajbouj M, Kalus P, Montag C, Seifert F, Wernicke C, Rommelspacher H, Rinneberg H, Schubert F: Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 2005;26:123-131.
48. Tork I: Raphe nuclei and serotonin containing system;in Paxinos G (ed): The Rat Nervous System. London, Academic Press, 1985, pp 43-78.
49. Moore RY, Halaris AE: Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat. J Comp Neurol 1975;164:171-183.
50. Brezun JM, Daszuta A: Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999;89:999-1002.
51. Brezun JM, Daszuta A: Serotonin may stimulate granule cell proliferation in the adult hippocampus, as observed in rats grafted with foetal raphe neurons. Eur J Neurosci 2000;12:391-396.
52. Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, Bartolomucci A, Fuchs E: Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001;98:12796-12801.
53. Thorre K, Chaouloff F, Sarre S, Meeusen R, Ebinger G, Michotte Y: Differential effects of restraint stress on hippocampal 5-HT metabolism and extracellular levels of 5-HT in streptozotocin-diabetic rats. Brain Res 1997;772:209-216.
54. McEwen BS, Conrad CD, Kuroda Y, Frankfurt M, Magarinos AM, McKittrick C: Prevention of stress-induced morphological and cognitive consequences. Eur Neuropsychopharmacol 1997;7(suppl 3):S323-S328.
55. Luine V, Villegas M, Martinez C, McEwen BS: Repeated stress causes reversible impairments of spatial memory performance. Brain Res 1994;639:167-170.
56. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-809.
57. Radley JJ, Jacobs BL: 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 2002;955:264-267.
58. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R: Serotonin 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002;416:396-400.
59. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA: Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004;306:879-881.
60. Fish DR, Gloor P, Quesney FL, Olivier A: Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy: pathophysiological implications. Brain 1993;116:397-414.
61. Seidenbecher T, Laxmi T R, Stork O, Pape HC: Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval. Science 2003;301:846-850.
62. Büchel C, Dolan RJ, Armony JL, Friston KJ: Amygdala-hippocampal involvement in human aversive trace conditioning revealed through event-related functional magnetic resonance imaging. J Neurosci 1999;19:10869-10876.
63. Gray JA: The neuropsychological basis of anxiety;in Handbook of Anxiety Disorder. New York, Pergamon Press, 1988, pp 10-40.
64. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig I W, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389.
65. Goldman D, Hu X, Zhu G, Lipsky R, Murphy D: The serotonin transporter: new alleles, function and phenotype. 3rd Ann Pharmacogent Psychiatry Meet, New York, 2004, pp 16-17.
66. Nakamura M, Ueno S, Sano A, Tanabe H: The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000;5:32-38.
67. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA: An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005;29:8-16.
68. Lang UE, Hellweg R, Gallinat J: Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 2005;30:1148-1153.
69. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T, Smolka M, Hegerl U, Rommelspacher H, Winterer G, Herrmann WM: Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 2003;28:530-532.
70. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U: The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000;148:404-411.
71. Gallinat J, Müller DJ, Bierbrauer J, Rommelspacher H, Juckel G, Wernicke C: Functional cortical effects of novel allelic variants of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) in humans. Pharmacopsychiatry 2007;40:191-195.
72. Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, Porteous DJ, Muir WJ, Blackwood DH, Evans KL: Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 2007;12:94-104.
73. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002;71:877-892.
74. Breen G, Prata D, Osborne S, Munro J, Sinclair M, Li T, Staddon S, Dempster D, Sainz R, Arroyo B, Kerwin RW, St CD, Collier D: Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry 2006;163:1636-1638.
75. Straub RE, Jiang Y, Maclean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002;71:337-348.
76. Detera-Wadleigh SD, McMahon FJ: G72/ G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006;60:106-114.
77. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La RP, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Urich-Costa J, Cherif D, Gimalac A, Van DC, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D: Genetic and physiological data implicating the new human gene G72 and the gene for D -amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002;99:13675-13680.
78. Fallgatter AJ, Herrmann MJ, Hohoff C, Ehlis AC, Jarczok TA, Freitag CM, Deckert J: DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology 2006;31:2002-2010.
79. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, Coppola R, Egan MF, Weinberger DR: The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006;31:2022-2032.
80. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
81. Gallinat J, Götz T, Kalus P, Bajbouj M, Sander T, Winterer G: Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neurosci 2007;19:59-68.
82. Reischies FM, Neuhaus AH, Hansen ML, Mientus S, Mulert C, Gallinat J: Electrophysiological and neuropsychological analysis of a delirious state: the role of the anterior cingulate gyrus. Psychiatry Res 2005;138:171-181.
83. Gallinat J, Mulert C, Bajbouj M, Herrmann WM, Schunter J, Senkowski D, Moukhtieva R, Kronfeldt D, Winterer G: Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002;17:110-127.
84. Hochreiter S, Schmidhuber J: Feature extraction through LOCOCODE. Neural Comput 1999;11:679-714.
85. Graepel T, Obermayer K: A stochastic selforganizing map for proximity data. Neural Comput 1999;11:139-155.
86. Gallinat J, Obermayer K, Heinz A: Systems neurobiology of the dysfunctional brain: schizophrenia. Pharmacopsychiatry 2007;40(suppl 1):S40-S44.